Analyst Optimism Boosts CVS, Lowe's, and Equinix Following Strong Earnings

Key Facts

1CVS Health received a 'Moderate Buy' recommendation with an average price target of $105.38.

2Lowe's was given a 'Moderate Buy' consensus rating after beating quarterly earnings with an EPS of $3.03.

3Equinix reported strong EPS of $10.79 with a 'Moderate Buy' rating from 26 brokerages.

Following weeks of anticipation for corporate results, updated analyst ratings have signaled a positive trend for several leading US equities. CVS Health received a 'Moderate Buy' recommendation with an average price target of $105.38, while Lowe's earned a similar rating after exceeding earnings estimates with an EPS of $3.03. Equinix also stood out with strong performance, reporting an EPS of $10.79, leading 26 brokerages to maintain a 'Moderate Buy' consensus.

Per market data, these valuations reflect analyst confidence in sustained growth despite sectoral headwinds. CVS shares closed at $110.60 (as of July 21, 2026), while LOW shares recorded a level of $204.35 (as of July 22, 2026). In the data center sector, EQIX showed significant strength, closing at $1,028.74 (as of July 22, 2026), reinforcing the bullish outlook held by brokerages toward high-yield stocks.

Looking ahead, traders are monitoring support and resistance levels based on recent snapshots, with MCHP closing at $85.02 and LDOS at $104.92 (as of July 21-22, 2026). In the absence of immediate catalysts in the upcoming economic calendar specifically for these firms, earnings reports and price target adjustments remain the primary drivers for short-term stock movement.